Normal range prostate-specific antigen versus age-specific prostate-specific antigen in screening prostate adenocarcinoma
- 31 August 1995
- Vol. 46 (2), 200-204
- https://doi.org/10.1016/s0090-4295(99)80194-0
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Serum PSA adjusted for volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostateUrology, 1994
- Cancer statistics, 1994CA: A Cancer Journal for Clinicians, 1994
- Prostate Specific Antigen Levels in Men Older than 50 Years without Clinical Evidence of Prostatic CarcinomaJournal of Urology, 1993
- Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference rangesJAMA, 1993
- The Inability of Prostate Specific Antigen Index to Enhance the Predictive Value of Prostate Specific Antigen in the Diagnosis of Prostatic CarcinomaJournal of Urology, 1993
- Screening for Prostatic Carcinoma with Prostate Specific Antigen: Results of the Second YearJournal of Urology, 1993
- Prostate-Specific Antigen, Digital Rectal Examination, and Transrectal Ultrasonography: Their Roles in Diagnosing Early Prostate CancerMayo Clinic Proceedings, 1993
- Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate diseaseJAMA, 1992
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerNew England Journal of Medicine, 1991
- Clinical Application of Transrectal Ultrasonography and Prostate Specific Antigen in the Search for Prostate CancerJournal of Urology, 1988